Literature DB >> 8751868

Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.

V S Rao1, A Cupples, C M van Duijn, A Kurz, R C Green, H Chui, R Duara, S A Auerbach, L Volicer, J Wells, C van Broeckhoven, J H Growdon, J L Haines, L A Farrer.   

Abstract

Apolipoprotein E (APOE) genotype is the single most important determinant to the common form of Alzheimer disease (AD) yet identified. Several studies show that family history of AD is not entirely accounted for by APOE genotype. Also, there is evidence for an interaction between APOE genotype and gender. We carried out a complex segregation analysis in 636 nuclear families of consecutively ascertained and rigorously diagnosed probands in the Multi-Institutional Research in Alzheimer Genetic Epidemiology study in order to derive models of disease transmission which account for the influences of APOE genotype of the proband and gender. In the total group of families, models postulating sporadic occurrence, no major gene effect, random environmental transmission, and Mendelian inheritance were rejected. Transmission of AD in families of probands with at least one epsilon 4 allele best fit a dominant model. Moreover, single gene inheritance best explained clustering of the disorder in families of probands lacking epsilon 4, but a more complex genetic model or multiple genetic models may ultimately account for risk in this group of families. Our results also suggest that susceptibility to AD differs between men and women regardless of the proband's APOE status. Assuming a dominant model, AD appears to be completely penetrant in women, whereas only 62%-65% of men with predisposing genotypes develop AD. However, parameter estimates from the arbitrary major gene model suggests that AD is expressed dominantly in women and additively in men. These observations, taken together with epidemiologic data, are consistent with the hypothesis of an interaction between genes and other biological factors affecting disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751868      PMCID: PMC1914898     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  67 in total

1.  Analysis of family resemblance. 3. Complex segregation of quantitative traits.

Authors:  N E Morton; C J MacLean
Journal:  Am J Hum Genet       Date:  1974-07       Impact factor: 11.025

2.  Complex segregation analysis with pointers.

Authors:  J M Lalouel; N E Morton
Journal:  Hum Hered       Date:  1981       Impact factor: 0.444

3.  Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.

Authors:  C M van Duijn; L M Havekes; C Van Broeckhoven; P de Knijff; A Hofman
Journal:  BMJ       Date:  1995-03-11

4.  Polymorphism at the apoprotein-E locus in relation to risk of coronary disease.

Authors:  A M Cumming; F W Robertson
Journal:  Clin Genet       Date:  1984-04       Impact factor: 4.438

5.  Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.

Authors:  J Nalbantoglu; B M Gilfix; P Bertrand; Y Robitaille; S Gauthier; D S Rosenblatt; J Poirier
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

6.  Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

Authors:  R Mayeux; R Ottman; G Maestre; C Ngai; M X Tang; H Ginsberg; M Chun; B Tycko; M Shelanski
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

7.  Apolipoprotein E polymorphism and coronary artery disease.

Authors:  H J Menzel; R G Kladetzky; G Assmann
Journal:  Arteriosclerosis       Date:  1983 Jul-Aug

Review 8.  Familial risks for Alzheimer disease from a population-based series.

Authors:  C Hirst; I M Yee; A D Sadovnick
Journal:  Genet Epidemiol       Date:  1994       Impact factor: 2.135

9.  ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease.

Authors:  S Sorbi; B Nacmias; P Forleo; S Latorraca; I Gobbini; L Bracco; S Piacentini; L Amaducci
Journal:  Neurosci Lett       Date:  1994-08-15       Impact factor: 3.046

10.  No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.

Authors:  J L Haines; M L Pritchard; A M Saunders; J M Schildkraut; J H Growdon; P C Gaskell; L A Farrer; S A Auerbach; J F Gusella; P A Locke; B L Rosi; L Yamaoka; G W Small; P M Conneally; A D Roses; M A Pericak-Vance
Journal:  Genomics       Date:  1996-04-01       Impact factor: 5.736

View more
  9 in total

1.  Bridging the Gap Between Genomics and Education.

Authors:  Stephen A Petrill; Laura M Justice
Journal:  Mind Brain Educ       Date:  2007-12-01

Review 2.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

3.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease.

Authors:  D J Stone; I Rozovsky; T E Morgan; C P Anderson; C E Finch
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

5.  Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.

Authors:  Christine Fennema-Notestine; Matthew S Panizzon; Wesley R Thompson; Chi-Hua Chen; Lisa T Eyler; Bruce Fischl; Carol E Franz; Michael D Grant; Amy J Jak; Terry L Jernigan; Michael J Lyons; Michael C Neale; Larry J Seidman; Ming T Tsuang; Hong Xian; Anders M Dale; William S Kremen
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2.

Authors:  U Finckh; K van Hadeln; T Müller-Thomsen; A Alberici; G Binetti; C Hock; R M Nitsch; G Stoppe; J Reiss; A Gal
Journal:  Neurogenetics       Date:  2003-07-24       Impact factor: 2.660

Review 7.  Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies.

Authors:  Irene López González; Paula Garcia-Esparcia; Franc Llorens; Isidre Ferrer
Journal:  Int J Mol Sci       Date:  2016-02-04       Impact factor: 5.923

8.  Polymorphisms in LMNA and near a SERPINA gene cluster are associated with cognitive function in older people.

Authors:  Christie Cluett; Carol Brayne; Robert Clarke; Grimley Evans; Fiona Matthews; David C Rubinsztein; Felicia Huppert; David J Llewellyn; Neil Rice; William Henley; Timothy M Frayling; Anna Murray; David Melzer
Journal:  Neurobiol Aging       Date:  2008-10-09       Impact factor: 4.673

9.  Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel.

Authors:  Lindsay A Farrer; Robert P Friedland; Abdalla Bowirrat; Kristin Waraska; Amos Korczyn; Clinton T Baldwin
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.